A cross-sectional study on the prevalence and extraesophageal symptoms of Gastroesophageal Reflux Disease(GERD) in patients with upper GI symptoms, visiting the outpatient departments of peripheral hospitals in Greece - GERDQ-XS
Study identifier:NIS-GGR-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A cross-sectional study on the prevalence and extraesophageal symptoms of GERD in patients with upper GI symptoms, visiting the outpatient departments of peripheral hospitals in Greece. The 'GERDQ-XS' Study
Medical condition
Gastroesophageal Reflux Disease
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
600
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Mar 2011
Study Completion Date: 01 Mar 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Visiting outpatient departments, if symtoms patients with upper GI symptoms, visiting the outpatient departments of peripheral hospitals in Greece | - |
Contacts
Investigators
Principal Investigator
Panagiotis Pontikis
AstraZeneca
